Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) Alone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of the Phase 3 Alcyone Study - María‐Victoria Mateos; Jesús F. San Miguel; Michèle Cavo; Joan Bladé Creixenti; Kenshi Suzuki; Andrzej Jakubowiak; Stefan Knop; Chantal Doyen; Paulo Lúcio; Zsolt Nagy; Luděk Pour; Sebastian Grosicki; et al. (2022)